Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Mouse (Murine) Polyclonal SELENBP1 Primary Antibody for WB - ABIN1537301
Zhang, Yu, Li, Jiang, Zhou: Utility of SAM68 in the progression and prognosis for bladder cancer. in BMC cancer 2015
Human Polyclonal SELENBP1 Primary Antibody for IHC, IHC (p) - ABIN4890362
Ðermadi Bebek, Valo, Pussila, Reyhani, Sarantaus, Lalowski, Baumann, Nyström: Inherited cancer predisposition sensitizes colonic mucosa to address Western diet effects and putative cancer-predisposing changes on mouse proteome. in The Journal of nutritional biochemistry 2014
High anti-SBP1 (show MEGF8 Antibodies) is associated with infertile women with premature ovarian failure.
Downregulation of selenium-binding protein 1 is associated with lung squamous cell carcinoma.
cysteine 57 is a critical determinant of SBP1 (show MEGF8 Antibodies) function and may play a significant role in mitochondrial function.
Data indicate that loss of SBP1 (show MEGF8 Antibodies) may play an independent contributing role in prostate cancer progression and its levels might be useful in distinguishing indolent from aggressive disease.
These results have revealed a novel mechanism that SELENBP1-mediated cancer inhibition is through altering lipid/glucose metabolic signaling pathways.
Decreased selenium-binding protein 1 mRNA expression is associated with renal cell carcinoma (show MOK Antibodies).
hSP56 (show FKBP4 Antibodies) plays an important role in regulating HIF-1alpha (show HIF1A Antibodies), which may be one of mechanisms of hSP56 (show FKBP4 Antibodies) expression in suppressing the malignant characteristics of prostate cancer cells.
the downregulated SELENBP1 expression was reactivated by inducing differentiation. Therefore, SELENBP1 is a potential pharmacological target for individualized CRC (show CALR Antibodies) treatment.
Decreased SELENBP1 expression is an early event in lung squamous cell cancer tumorigenesis.
The expression level of SELENBP1 could be an important marker for predicting survival and effectiveness of selenium supplementation in breast cancer.
Selenbp1 suppresses the expression of tumor-promoting genes
SBP1 (show HMGB1 Antibodies) has tumor suppressor functions that are inhibited in colorectal cancer through epigenetic silencing
Selenium-Binding Protein1 (SBP1 (show HMGB1 Antibodies)) gene expression was studied in Arabidopsis thaliana seedlings challenged with several stresses.
This gene encodes a member of the selenium-binding protein family. Selenium is an essential nutrient that exhibits potent anticarcinogenic properties, and deficiency of selenium may cause certain neurologic diseases. The effects of selenium in preventing cancer and neurologic diseases may be mediated by selenium-binding proteins, and decreased expression of this gene may be associated with several types of cancer. The encoded protein may play a selenium-dependent role in ubiquitination/deubiquitination-mediated protein degradation. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
selenium-binding protein 1
, selenium-binding protein 1-B
, selenium binding protein 1
, selenium-binding protein 1-like
, 56 kDa selenium-binding protein
, selenium binding protein 2
, selenium-binding protein 2
, selenium-binding protein 1-A